BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 12794758)

  • 1. Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines.
    Arnold CN; Goel A; Boland CR
    Int J Cancer; 2003 Aug; 106(1):66-73. PubMed ID: 12794758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on DNA methylation and expression of hMLH1 in ovarian cancer cell line COC1/DDP].
    Meng CF; Dai DQ; Guo KJ
    Ai Zheng; 2008 Dec; 27(12):1251-5. PubMed ID: 19079988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter.
    Plumb JA; Strathdee G; Sludden J; Kaye SB; Brown R
    Cancer Res; 2000 Nov; 60(21):6039-44. PubMed ID: 11085525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of hMLH1 correlates with reduced 5-fluorouracil-mediated apoptosis in colon cancer cells.
    Fujita H; Kato J; Horii J; Harada K; Hiraoka S; Shiraha H; Sakaguchi K; Shiratori Y
    Oncol Rep; 2007 Nov; 18(5):1129-37. PubMed ID: 17914563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression.
    Deng G; Chen A; Hong J; Chae HS; Kim YS
    Cancer Res; 1999 May; 59(9):2029-33. PubMed ID: 10232580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on P16, hMLH1 and MGMT genes and DNA methylation in human gastric cancer cells].
    Meng CF; Zhu XJ; Dai DQ; Peng G
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):494-7. PubMed ID: 19742343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and promoter methylation status of mismatch repair gene hMLH1 and hMSH2 in epithelial ovarian cancer.
    Zhang H; Zhang S; Cui J; Zhang A; Shen L; Yu H
    Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):505-9. PubMed ID: 19032668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer.
    Ide T; Kitajima Y; Ohtaka K; Mitsuno M; Nakafusa Y; Miyazaki K
    Oncol Rep; 2008 Jun; 19(6):1571-6. PubMed ID: 18497967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: the predominant role of hMLH1.
    Wheeler JM; Beck NE; Kim HC; Tomlinson IP; Mortensen NJ; Bodmer WF
    Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10296-301. PubMed ID: 10468602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reversal effect of 5-Aza-dc on cisplatin-resistance in human NSCLC cells in vitro].
    Wu F; Hu CH
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):349-53. PubMed ID: 21875463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of colorectal cancer cell lines treated with paclitaxel, radiation, and 5-FU: effect of TP53 or hMLH1 deficiency.
    Kennedy AS; Harrison GH; Mansfield CM; Zhou XJ; Xu JF; Balcer-Kubiczek EK
    Int J Cancer; 2000 Aug; 90(4):175-85. PubMed ID: 10993958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses.
    Meyers M; Wagner MW; Hwang HS; Kinsella TJ; Boothman DA
    Cancer Res; 2001 Jul; 61(13):5193-201. PubMed ID: 11431359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of 5-Aza-dC on 5-Fu chemosensitivity by modulating TIP30 gene expression in human colorectal cancer cells].
    Chen XB; Chen BB; Li J; Wang XF; Ma YJ; Luo SX; Lü HF
    Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):824-7. PubMed ID: 24447479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1.
    Fleisher AS; Esteller M; Harpaz N; Leytin A; Rashid A; Xu Y; Liang J; Stine OC; Yin J; Zou TT; Abraham JM; Kong D; Wilson KT; James SP; Herman JG; Meltzer SJ
    Cancer Res; 2000 Sep; 60(17):4864-8. PubMed ID: 10987299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
    Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
    Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma.
    Herman JG; Umar A; Polyak K; Graff JR; Ahuja N; Issa JP; Markowitz S; Willson JK; Hamilton SR; Kinzler KW; Kane MF; Kolodner RD; Vogelstein B; Kunkel TA; Baylin SB
    Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6870-5. PubMed ID: 9618505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histone H3 lysine 9 methylation is associated with the expression of hMLH1 and DNA methylation in gastric cancer cells].
    Meng CF; Zhu XJ; Peng G
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2490-3. PubMed ID: 19080631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Methylation of mismatch repair gene (MMR) in primary hepatocellular carcinoma].
    Zhang CJ; Li HM; Yau LM; Suen KW; Zhou GY; Yu F; Liew CT
    Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):433-6. PubMed ID: 15498213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense inhibition of hMLH1 is not sufficient for loss of DNA mismatch repair function in the HCT116+chromosome 3 cell line.
    Chauhan DP; Yang Q; Carethers JM; Marra G; Chang CL; Chamberlain SM; Boland CR
    Clin Cancer Res; 2000 Oct; 6(10):3827-31. PubMed ID: 11051225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of DNA methylation status analyzed by bisulfite-PCR-SSCP and correlation with clinico-pathological characteristics in colorectal cancer.
    Maekawa M; Sugano K; Ushiama M; Fukayama N; Nomoto K; Kashiwabara H; Fujita S; Kakizoe T
    Clin Chem Lab Med; 2001 Feb; 39(2):121-8. PubMed ID: 11341745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.